Full Enrollment of Phase 3 4WARD Trial Expected in 2H25 X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is currently evaluating mavorixafor in a Phase 3 clinical trial in chronic neutropenia (CN ...

BNT327 combined with chemotherapy showed an overall response rate of 85.4% when used as a first-line treatment for extensive-stage small cell lung cancer. The PD-L1 and VEGF-A bispecific antibody ...

The markers of inflammation of the first blood test performed at admittance were also collected: CRP, fibrinogen, ferritin, lactate dehydrogenase (LDH), PCT, IL-6, D-dimer, and complete blood count.

With regard to comrade Shivambu's conviction on the second count for issuing a statement on Botswana ... review such a decision. 72. When comrade Malema joined the ANC he undertook in his membership ...

Given these findings, a practical approach is to monitor white blood cell (WBC) count with a differential (including absolute neutrophil count) once a week in patients who are receiving vancomycin ...

FILE: The DA and ANC entered into an arrangement in the Government of National Unity. Picture: GCIS JOHANNESBURG - The ANC will this weekend meet with its two Government of National Unity (GNU ...

Neutrophils play a crucial role in the immune response, acting as the most abundant white blood cells responsible for frontline defense against infections ...

FILE: The DA and ANC entered into an arrangement in the Government of National Unity. Picture: GCIS JOHANNESBURG - Following weeks of public spats and a deadlock over the budget, the African ...

including clinical results from the completed Phase 2 clinical trial and research focused on assessing the ability of mavorixafor monotherapy to durably increase absolute neutrophil count in ...